# Lovastatin in Treating Patients At High Risk of Melanoma

> **NCT00462280** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 80 (actual)

## Conditions studied

- Precancerous Condition
- Stage 0 Melanoma
- Stage I Melanoma
- Stage II Melanoma

## Interventions

- **DRUG:** lovastatin
- **OTHER:** placebo
- **PROCEDURE:** biopsy
- **PROCEDURE:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00462280
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2011-04
- **Final completion:** 2012-02
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2014-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00462280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00462280, "Lovastatin in Treating Patients At High Risk of Melanoma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00462280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*